Home > Result Summaries: Compounds > abacavir/lamivudine Result Summaries: abacavir/lamivudine GSKStudy ID Phase Title Summary (Download) 103441 Phase 3 A Randomised, Open-Label Study to Evaluate the Efficacy and Safety of a treatment optimisation with Trizivir during 96 weeks after a first antiretroviral treatment in HIV-1 Infected Subjects (0 citation(s)) 104807 Phase 4 Post-Marketing Clinical Study of EPZICOM Tablet (Lamivudine / Abacavir Sulfate) – Pharmacokinetic Study in HIV-Infected Patients – (0 citation(s)) 107362 phase 4 HIV Model Fixed Dosed Combination Outcomes (1 citation(s)) 111950_4 n\a Fractures over time stratified by HIV infection and Antiretroviral Therapy (ART) exposure (0 citation(s)) 112872_4 n\a HIV treatment and CVD events - Ingenix. Retrospective Database Analysis of Patients with Human Immunodeficiency Virus (HIV) Treatment and Cardiovascular Disease (CVD) Events (0 citation(s)) 112877_6 N/A Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration (5 citation(s)) 112878_6 N/A Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency Virus (0 citation(s)) 112879_1 N/A Incidence of abacavir hypersensitivity reactions in EuroSIDA (1 citation(s)) 112885_4 N/A Antiretroviral Pregnancy Registry (APR)-Risk of birth defects associated with exposure to GSK HIV drugs during pregnancy (1 citation(s)) 112887_4 N/A Studies using DAD - Effects of different interventions to improve ART-associated dyslipidemia (1 citation(s)) 113039_4 N/A Studies using DAD - Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: Are different antiretroviral drugs associated with different lipid profiles? (1 citation(s)) 113156_4 N/A Studies using the VA - Studies done under the Oversight Committee for the Evaluation of the metabolic complications of HAART (2 citation(s)) 113329_4 n\a Lactic acid levels in children pre- and perinatally treated with antiretrovirals to prevent HIV transmission (Giaquinto; Hyperlactatemia in infants with in utero exposure to ZDV/3TC ) (2 citation(s)) 113734 phase 4 A Prospective, Randomized, Multicenter, Open-Label Study to Compare the Efficacy and Safety of Simplifying from a Regimen of Atazanavir (ATV) + Ritonavir (RTV) + Tenofovir/Emtricitabine to ATV + Abacavir/Lamivudine Without RTV in Virologically Suppressed, HIV-1 Infected, HLA-B*5701 Negative Subjects (4 citation(s)) ESS30009 Phase 3 A phase III, randomized, open-label, multicenter study of the safety and efficacy of efavirenz versus tenofovir when administered in combination with the abacavir/lamivudine fixed-dose combination tablet as a once-daily regimen in antiretroviral-naive HIV-1 infected subjects. (1 citation(s))
